Categories
GeekWire

Institute looks into boosting COVID-19 vaccine

Peter Hotez and Maria Elena Bottazzi
Peter Hotez and Maria Elena Bottazzi work in their lab at Texas Children’s Hospital Center for Vaccine Development, where their research team developed a vaccine candidate that may be able to protect against COVID-19. (Baylor College of Medicine Photo)

Seattle’s Infectious Disease Research Institute is working with Houston’s Baylor College of Medicine to multiply the doses of a potential COVID-19 vaccine by 30 to 100 times. Other partners in the effort include Seattle-based PATH and Texas Children’s Hospital Center for Vaccine Development.

If the project proceeds as planned, Baylor and its partners could repurpose a vaccine candidate originally created to counter a different coronavirus-based disease known as severe acute respiratory syndrome, or SARS, to fight off COVID-19.

Get the full story on GeekWire.

By Alan Boyle

Mastermind of Cosmic Log, contributing editor at GeekWire, author of "The Case for Pluto: How a Little Planet Made a Big Difference," president of the Council for the Advancement of Science Writing. Check out "About Alan Boyle" for more fun facts.

Leave a Reply